https://news.augustaheadlines.com/story/466989/on-march-12-the-press-conference-of-the-44th-china-fuzhou-international-automobile-expo-2024-was-held-grandly.html 2024-04-26T12:24:08+00:00 daily 1.0 https://news.augustaheadlines.com/story/466988/pcsk9-inhibitors-market-to-witness-upsurge-in-growth-during-forecast-period-20242034-examine-delveinsight-sirnaomics-vaxxinity-verve-therapeutics-xinlitai-biotech-novo-nordisk-astrazeneca.html 2024-04-26T12:04:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/466976/the-3d-urology-and-prostate-clinics-introduce-groundbreaking-nonsurgical-prostate-treatments-for-revolutionizing-prostate-disease-care.html 2024-04-26T11:39:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/466987/janus-kinase-jak-inhibitors-pipeline-drugs-analysis-report-2024-updates-fda-approvals-clinical-trials-therapies-moa-roa-by-delveinsight-aclaris-therapeutics-pfizer-eqrx-celon-pharma.html 2024-04-26T11:34:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/466986/remoove-ltd-revolutionizing-advertising-with-innovative-solutions.html 2024-04-26T11:22:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/466985/taskport-unveils-the-nextgen-aipowered-app-transforming-how-to-collaborate-and-balance-work-and-life.html 2024-04-26T11:14:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/466984/reserve-dermatology-and-aesthetics-is-opening-an-allnew-facility.html 2024-04-26T11:04:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/466983/burns-pipeline-and-clinical-trials-assessment-2024-updates-fda-approvals-therapies-and-key-companies-involved-by-delveinsight-mediwound-kaken-pharma-kerecis-medline-mallinckrodt-pharma.html 2024-04-26T10:56:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/466982/cholestatic-pruritus-market-to-observe-impressive-growth-during-the-forecast-period-20232032-evaluates-delveinsight-escient-pharma-glaxosmithkline-mirum-pharma-albireo-regeneron-pharma.html 2024-04-26T10:38:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/466981/dermatomyositis-market-to-register-incremental-growth-during-the-forecast-period-20232032-asserts-delveinsight-astrazeneca-plc-bristolmyers-squibb-company-pfizer-inc-octapharma-ag-corbus.html 2024-04-26T10:24:04+00:00 daily 1.0